lymphokine-activated killer cells

BIOLOGICAL6 trials

Sponsors

St. Luke's Medical Center, Weill Medical College of Cornell University, Dartmouth-Hitchcock Medical Center, Lisata Therapeutics, Inc.

Conditions

Brain and Central Nervous System TumorsColorectal CancerKidney CancerMelanoma (Skin)

Phase 1

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

St. Luke's Medical CenterMelanoma (Skin)

Start: 2000-11-30Target: 18Updated: 2013-09-20

Bispecific Antibody Plus White Blood Cells in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme

CompletedNCT00005813

Dartmouth-Hitchcock Medical CenterBrain and Central Nervous System Tumors

Start: 1997-03-31End: 2003-01-31Updated: 2011-10-27

Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer

St. Luke's Medical CenterColorectal Cancer, Kidney Cancer

Start: 2001-01-31Updated: 2013-09-20

Phase 2

Biological Therapy in Treating Patients With Primary or Advanced Glioma

SuspendedNCT00003067

Weill Medical College of Cornell UniversityBrain and Central Nervous System Tumors

Start: 1997-07-31Updated: 2009-02-09

Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

CompletedNCT00002535

St. Luke's Medical CenterMelanoma (Skin)

Start: 1993-07-31End: 2004-07-31Updated: 2013-06-26

Lymphokine-Activated Killer Cells or Gliadel Wafer in Treating Patients With Newly Diagnosed Glioblastoma Multiforme That Can Be Removed by Surgery

WithdrawnNCT00814593

Lisata Therapeutics, Inc.Brain and Central Nervous System Tumors

Start: 2008-11-30End: 2011-09-30Updated: 2019-05-10